Cancer therapies and drug activation enhanced by global photonics research
A simple pulse of light can control the activity of a molecule at a specific location without affecting surrounding cells, thereby limiting unwanted side-effects. Image: Gotta lab – UNIGE
Photonics-based medical research is targeting drug activation and cancer photoimmunotherapy with studies from the University of Geneva, Southeast University, China and Kent State University, US.
Register for FREE to keep reading
Join 15,000+ photonics professionals staying ahead with:
- Exclusive insights, funding alerts & market trends
- Curated newsletters and digital editions
- Access to The Photonics100 list of R&D champions
- Exclusive panels & roundtables for professional development
- Technical White Papers & product updates to guide smarter decisions
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
